AKT1 and cancer: Despite this, the consistent enrichment of key oncogenic pathways—such as PI3K/AKT and MAPK signaling—in both the original and randomized settings support their centrality in cancer progression and aligns with the transcription factor disruptions identified in the pancreatic cancer subnetwork.